Associate Professor Barry Slobedman, Westmead Millenium Institute of Medical Research.
Associate Professor Barry Slobedman obtained a BSc (with Honours) and a PhD in molecular virology from the University of Adelaide, studying herpes simplex virus latency. He then moved to Stanford University (USA) where he trained as a post-doctoral research fellow at the Stanford University Medical Center in the Department of Microbiology and Immunology, studying latency and pathogenesis of human cytomegalovirus (HCMV), with a Fellowship from the American Heart Association. He returned to Australia as a Rolf Edgar Lake Fellow at the Westmead Millennium Institute/University of Sydney and established an independent research group in 2000.
The overall goal of his research program is to define the mechanisms which underpin the capacity of herpesviruses to persist and cause disease in the human population. In particular, his work focuses on defining the mechanisms by which HCMV limits host defences to enhance its capacity to cause life-threatening disease in individuals who are immunosuppressed, and he also works collaboratively on the neuropathogenesis and immune evasion of varicella zoster virus (VZV). He is currently Associate Professor in the Discipline of Infectious Diseases and Immunology, University of Sydney. He has held continuous NHMRC Project and/or NHMRC Program Grant funding throughout his career and is an Editorial Board member of the Journal of General Virology and Herpesviridae, and is the past Treasurer of the Australasian Virology Society. In 2012 he was awarded the Sir Zelman Cowan Universities Fund Prize for Discovery in Medical Research for his work on immune evasion by latent HCMV.